NCT03249753View on ClinicalTrials.gov

The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 23, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Hypertension
Interventions
DRUG

SPH3127 200mg Panel A

Participants who are in panel A will receive a single dose of a SPH3127 tablets 200mg when limosis, then fast 4h after dosing, and 72 hours later participants take the second dose of SPH3127 200mg after a high-fat breakfast.

DRUG

SPH3127 200mg Panel B

Participants who are in panel B will receive a single dose of a SPH3127 tablets 200mg after a high-fat breakfast, then 72 hours later participants take the second dose of SPH3127 200mg when limosis.

Trial Locations (1)

100029

The capital medical university affiliated Beijing anzhen hospital, Beijing

All Listed Sponsors
lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY

NCT03249753 - The Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects | Biotech Hunter | Biotech Hunter